Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01276587 · ClinicalTrials.gov registry record · Phase 1
Study of Vitamin D in Children With Sickle Cell Disease
A Phase 1 study, sponsored by Gary M Brittenham, MD.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT01276587 is a Phase 1 study that has completed, run by Gary M Brittenham, MD. The registered enrollment target is 4 participants.
The verdict
NCT01276587, a Phase 1 study, has completed, sponsored by Gary M Brittenham, MD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
This pilot study aims to answer the question whether monthly oral vitamin D3 supplementation, 100,000 IU, will be safe and effective in raising serum 25-hydroxyvitamin D (form of vitamin D measured in the blood) to levels considered sufficient (30 ng/mL) but well below the threshold for toxicity (150 ng/mL) in children with sickle cell disease. Information from this study will be crucial before we perform a larger clinical trial to determine the effects of vitamin D in reducing respiratory complications in patients with sickle cell disease.
Interventions
- DRUG Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2011-01 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01276587
The ClinicalTrials.gov registry entry for NCT01276587 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gary M Brittenham, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT01276587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01276587 about?
NCT01276587 is a clinical study titled "Study of Vitamin D in Children With Sickle Cell Disease". This pilot study aims to answer the question whether monthly oral vitamin D3 supplementation, 100,000 IU, will be safe and effective in raising serum 25-hydroxyvitamin D (form of vitamin D measured in the blood) to levels considered sufficient (30 ng/mL) but well below the threshold for toxicity (15...
What is the current status of trial NCT01276587?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2011-01. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01276587?
The interventions under investigation include: Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01276587?
This trial is sponsored by Gary M Brittenham, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.